NMRA compared with SEER: revenue, margins and what each company keeps, and the suppliers and customers both name

NMRANeumora Therapeutics, Inc.

Mkt capRevenueRevenue

SEERSeer, Inc.

Mkt capRevenueRevenue

Compare

NMRANeumora Therapeutics, Inc.

SEERSeer, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

NMRA: latest quarter not drawable. SEER: latest quarter is a loss; flow not drawable.Method ›

Price

rebased to 0%

NMRA, solidSEER, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only NMRA 4

AMGNAmgensupplier

—The Scripps Research Institute (TSRI)unlistedsupplier

—Warren Center for Neuroscience Drug Discovery at Vanderbilt Universityunlistedsupplier

—Vanderbiltunlistedsupplier

Shared 0

No shared counterparties.

Only SEER 5

—PrognomiQunlistedcustomer

—Hamiltonunlistedsupplier

—The Brigham and Women's Hospital, Inc. (BWH)unlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—Discovery Life Sciencesunlistedcustomer

1 more · SEER chain ›

NMRANeumora Therapeutics, Inc.

0.39▼−0.77%· post 0.36

Mkt cap$69.0MRevenue—Revenue—

SEERSeer, Inc.

1.69▼−12.74%· post 1.69

ClosedOct 30 '26

Mkt cap$93.0MRevenue$3MQ2 FY26Revenue$17MFY25

Compare

ClosedOct 30 '26

NMRANeumora Therapeutics, Inc.

SEERSeer, Inc.

0.39▼−0.77%post 0.36

Price

1.69▼−12.74%post 1.69

$69.0M

Mkt cap

$93.0M

—

Revenue

$3MQ2 FY26

—

Revenue

$17MFY25

NMRA0.39▼−0.77%vsSEER1.69▼−12.74%ClosedOct 30 '26